Prediction of new-onset atrial fibrillation in patients with non-small cell lung cancer treated with curative-intent conventional radiotherapy.
Publication Date: 2024 Sep 26
Full Text Sources
Authors
Fariba Tohidinezhad; Leonard Nürnberg; Femke Vaassen; Rachel Ma Ter Bekke; Hugo Jwl Aerts; Lizza El Hendriks; Andre Dekker; Dirk De Ruysscher; Alberto TraversoAbstract
OBJECTIVE
Atrial fibrillation (AF) is an important side effect of thoracic Radiotherapy (RT), which may impair quality of life and survival. This study aimed to develop a prediction model for new-onset AF in patients with Non-Small Cell Lung Cancer (NSCLC) receiving RT alone or as a part of their multi-modal treatment.
Source
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
Pub Types(s)
Journal Article
Language
English
PubMed ID
39341504